Glenmark Pharmaceuticals
GLENMARK.NS
#2573
Rank
โ‚น423.23 B
Marketcap
โ‚น1,500
Share price
-2.94%
Change (1 day)
50.92%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): โ‚น9.02

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น9.39. In 2022 the company made an earnings per share (EPS) of โ‚น33.26 a decrease over its 2021 EPS that were of โ‚น41.67.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น9.02-72.88%
2022โ‚น33.26-20.18%
2021โ‚น41.677.13%
2020โ‚น38.9025.72%
2019โ‚น30.94-22.01%
2018โ‚น39.6730.15%
2017โ‚น30.48-34.82%
2016โ‚น46.7763.09%
2015โ‚น28.689.68%
2014โ‚น26.14-26.58%
2013โ‚น35.610.51%
2012โ‚น35.43